A new international trial led by the Murdoch Children's Research Institute is testing a pneumococcal vaccine that targets more strains of the deadly bacteria. The study is recruiting infants to evaluate the vaccine's safety and effectiveness.
Breakdown
- A new pneumococcal vaccine trial is underway, led by the Murdoch Children's Research Institute. 32s
- The vaccine targets 21 strains of pneumococcal bacteria, up from the current 13. 55s
- The trial is recruiting 1,600 babies globally to test the vaccine alongside standard immunisations. 1m 11s
- Pneumococcal disease can cause serious illness or death in children under two. 1m 27s
- Healthy babies under two months old who have not had their first vaccinations are eligible to participate. 1m 48s